You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 118 No. 7, July 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CASE REPORTS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Pyoderma Gangrenosum

Occurrence With Altered Cellular Immunity and a Circulating Serum Factor

Steven J. Greenberg, MD; Brian V. Jegasothy, MD; Robert B. Johnson, MD; Gerald S. Lazarus, MD

Arch Dermatol. 1982;118(7):498-502.


Abstract



• Aberrations of cellular immune functions in pyoderma gangrenosum (PG) may lead to nonspecific activation of inflammatory cells or to an imbalance of suppression leading to autoaggression (chronic ulceration). A patient with severe unremitting PG had anergy to a battery of seven skin test antigens. Mixed lymphocyte reactions, autologous mixed lymphocyte reactions, lymphocyte proliferative responses to antigens, and the production of leukocyte inhibitory factor were substantially suppressed, while the lymphocyte responses to mitogens were unaffected. Quantitative immunoglobulin and complement levels were normal. The inhibition of cellular immune functions was mediated by a factor in the patient's serum. This factor also inhibited lymphocyte functions of normal unrelated control subjects. Preliminary studies demonstrated that the factor is nondialyzable, heat stable, and not adsorbed by Staphylococcus A protein. Pulse therapy with large doses of corticosteroids resulted in dramatic clinical improvement.

(Arch Dermatol 1982;118:498-502)



Author Affiliations



From the Departments of Microbiology and Immunology (Dr Greenberg) and Medicine (Drs Jegasothy, Johnson, and Lazarus), Division of Dermatology, Duke University Medical Center, Durham, NC.


Footnotes



Accepted for publication Dec 10, 1981.

Reprint requests to Box 3137, Duke University Medical Center, Durham, NC 27710 (Dr Jegasothy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Present Status of Pyoderma Gangrenosum: Review of 21 Cases
Prystowsky et al.
Arch Dermatol 1989;125:57-64.
ABSTRACT  

Pyoderma Gangrenosum in a Patient With HTLV-III Antibody
Schwartz et al.
Arch Dermatol 1986;122:508-509.
ABSTRACT  

Pyoderma Gangrenosum Involving the Head and Neck
Snyder
Arch Dermatol 1986;122:295-302.
ABSTRACT  

Commentary: Pyoderma Gangrenosum
Newell and Malkinson
Arch Dermatol 1982;118:769-773.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.